The multiple hit hypothesis for Gulf War illness: self-reported chemical/biological weapons exposure and mild traumatic brain injury - Janulewicz P, Krengel M, Quinn E, Heeren T, Toomey R, Killiany R, Zundel C, Ajama J, O'Callaghan J, Steele L, Klimas N, Sullivan K.
The Gulf War Illness Consortium (GWIC) was designed to identify objective biomarkers of Gulf War Illness (GWI) in 1991 Gulf War veterans. The symptoms of GWI include fatigue, pain, cognitive problems, gastrointestinal, respiratory, and skin problems. Neuro... (Source: SafetyLit)
Source: SafetyLit - November 17, 2018 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

New inhibitor which blocks inflammation could also treat sepsis
(University of Sheffield) Scientists from the University of Sheffield have discovered a new inhibitor which decreases lung inflammation and could hold the key to treating Acute Respiratory Distress Syndrome -- a life-threatening disease which affects thousands of people in the UK. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 17, 2018 Category: Infectious Diseases Source Type: news

Air Quality in California: Devastating Fire Leads to a New Danger
A week after the most destructive fire in state history ripped through this small town, the flames have been replaced by a new danger: the air. (Source: NYT Health)
Source: NYT Health - November 16, 2018 Category: Consumer Health News Authors: JULIE TURKEWITZ and MATT RICHTEL Tags: Fires and Firefighters Hazardous and Toxic Substances Immune System Wildfires Respiratory System California Source Type: news

Vapotherm closes $64m IPO
Vapotherm said today it closed its initial public offering, raising a total $64.4 million in gross proceeds. The Exeter, N.H.-based company developed the Precision Flow line of devices to provide high-velocity heated, humidified and oxygenated air to treat patients with conditions such as pneumonia, chronic obstructive pulmonary disease, asthma and heart failure. Some 1,200 of the devices have been sold in the U.S., mostly into hospital ICUs, the company said. Vapotherm said it floated 4.6 million shares of its common stock at $14 per share, and that the offering featured a fully exercised underwriter’s option to pur...
Source: Mass Device - November 16, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Initial Public Offering (IPO) Respiratory Wall Street Beat Vapotherm Source Type: news

Patients Hospitalized for COPD Rarely Receive Pulmonary Rehab
Elderly, those living>10 miles from facility, those with lower SES less likely to receive pulmonary rehab (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - November 16, 2018 Category: Respiratory Medicine Tags: Internal Medicine, Nursing, Pulmonology, Geriatrics, Journal, Source Type: news

ACAAI: Hospital Stay, Caregiver Knowledge of Asthma Linked
Children of caregivers with poor asthma knowledge more likely to have prolonged hospital stay (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - November 16, 2018 Category: Respiratory Medicine Tags: Family Medicine, Nursing, Pediatrics, Pulmonology, Allergy, Emergency Medicine, Conference News, Source Type: news

Smoke Spreading From California Fires Sparks Health Concerns
Smoke masks. Eye drops. No outdoor exercise. This is how Californians are trying to cope with wildfires choking the state, but experts say an increase in serious health problems may be almost inevitable for vulnerable residents as the disasters become more commonplace. Research suggests children, the elderly and those with existing health problems are most at risk. Short-term exposure to wildfire smoke can worsen existing asthma and lung disease, leading to emergency room treatment or hospitalization, studies have shown. Increases in doctor visits or hospital treatment for respiratory infections, bronchitis and pneumonia i...
Source: JEMS: Journal of Emergency Medical Services News - November 16, 2018 Category: Emergency Medicine Authors: Lindsey Tanner, AP Medical Writer Tags: Patient Care News Source Type: news

Smoke Spreading From California Fires Sparks Health Concerns
Smoke masks. Eye drops. No outdoor exercise. This is how Californians are trying to cope with wildfires choking the state, but experts say an increase in serious health problems may be almost inevitable for vulnerable residents as the disasters become more commonplace. Research suggests children, the elderly and those with existing health problems are most at risk. Short-term exposure to wildfire smoke can worsen existing asthma and lung disease, leading to emergency room treatment or hospitalization, studies have shown. Increases in doctor visits or hospital treatment for respiratory infections, bronchitis and pneumonia i...
Source: JEMS Patient Care - November 16, 2018 Category: Emergency Medicine Authors: Lindsey Tanner, AP Medical Writer Tags: Patient Care News Source Type: news

GE divests $1.5B in healthcare equipment loan portfolio to TIAA Bank
General Electric (NYSE:GE) has divested a portfolio of its healthcare equipment leases and loans from its GE Capital Healthcare Equipment Finance biz to TIAA Bank in a $1.5 billion deal as GE looks to trim down and narrow its focus, the companies said today. Jacksonville, Fla.-based TIAA Bank said today that the acquisition will expand its commercial banking business and its ability to provide a full range of financial solutions to an increased number of healthcare providers. “This agreement with GE Capital supports our long-term asset growth plan and provides scale and portfolio diversification while significan...
Source: Mass Device - November 16, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Mergers & Acquisitions Wall Street Beat General Electric tiaabank Source Type: news

Chemosensitizers As Therapeutic Adjuncts in Allergic Airway Disease
Conference abstracts (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - November 16, 2018 Category: Respiratory Medicine Authors: GAtherton Source Type: news

A Health Literacy Readability Analysis of Online Allergy and Immunology-Based Patient Education Resources
Conference abstracts (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - November 16, 2018 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Comparison of Airborne Mold in the Mojave Desert and Las Vegas
Conference abstracts (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - November 16, 2018 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Diversity of Viable Airborne Fungi in Tulsa, Oklahoma
Conference abstracts (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - November 16, 2018 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Study on the Clinical and Immunological Characteristics of Fungal Sensitive Asthma and Allergic Bronchopulmonary Aspergillosis
Conference abstracts (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - November 16, 2018 Category: Respiratory Medicine Authors: GAtherton Source Type: news

KCNJ2 overexpression induces pro-inflammatory cytokine production, impaired barrier function and acantholysis in esophageal epithelial cells
Conference abstracts (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - November 16, 2018 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Defining the Extent of Allergenic Cross-reactivity among Mold Species
Conference abstracts (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - November 16, 2018 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Clinical Findings of Patients with Autonomal Dominant Hyper IgE Syndrome (HIES) in Usidnet
Conference abstracts (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - November 16, 2018 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Omalizumab Treatment in Patients with Cystic Fibrosis (CF) and Allergic Bronchopulmonary Aspergillosis (ABPA): a Case Series
Conference abstracts (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - November 16, 2018 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Mold Spore Release during Simulated Flooding and High Humidity
Conference abstracts (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - November 16, 2018 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Pets Can Double as Asthma Antidote
Title: Pets Can Double as Asthma AntidoteCategory: Health NewsCreated: 11/16/2018 12:00:00 AMLast Editorial Review: 11/16/2018 12:00:00 AM (Source: MedicineNet Asthma General)
Source: MedicineNet Asthma General - November 16, 2018 Category: Respiratory Medicine Source Type: news

Pulmonx wins Aetna coverage for Zephyr endobronchial valve
Pulmonx said yesterday that it won national coverage through health insurer Aetna for its Zephyr endobronchial valve system intended for treating severe emphysema and chronic obstructive pulmonary disorder. The coverage will make the Zephyr valve available to Aetna’s 22 million members, the Redwood City, Calif.-based company said. Under its new policy, Aetna specifically named the Zephyr as an approved bronchoscopic option for lung volume reduction, considering it medically necessary for the broncoscopic treatment of adult patients with hyperinflation associated with severe emphysema in regions of the lung with littl...
Source: Mass Device - November 15, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Respiratory Pulmonx Source Type: news

FDA to Ban Most Flavored E-Cigs; Starts to Move Against Menthol Cigarettes
(MedPage Today) -- Long-awaited steps finally announced (Source: MedPage Today Pulmonary)
Source: MedPage Today Pulmonary - November 15, 2018 Category: Respiratory Medicine Source Type: news

How Digital Health Technologies Could Make a Difference
Digital technologies are already changing healthcare. Adherium’s Hailie sensor, for instance, which transforms a traditional inhaler into a smart device, is already reportedly demonstrating reductions in emergency hospital visits. Mark Jones, vice president of R&D for Adherium, will share the story behind Hailie at BIOMEDevice San Jose’s Digital Health Product Spotlight on December 6. He’ll be joined by other digital technology trailblazers Angela McIntyre, executive director of eWear (Stanford Wearable Electronics Initiative); Chalisa Prarasri, CEO & co-founder...
Source: MDDI - November 15, 2018 Category: Medical Devices Authors: Daphne Allen Tags: BIOMEDevice San Jose Digital Health Source Type: news

Why Are So Few COPD Patients Getting Vital Rehab Treatment?
(Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - November 15, 2018 Category: Respiratory Medicine Tags: Nursing, Pulmonology, Preventive Medicine, News, Source Type: news

World Antibiotic Awareness Week
Thu, 11/15/2018 - 08:14News blog (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - November 15, 2018 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Why Are So Few COPD Patients Getting Vital Rehab Treatment?
Title: Why Are So Few COPD Patients Getting Vital Rehab Treatment?Category: Health NewsCreated: 11/15/2018 12:00:00 AMLast Editorial Review: 11/15/2018 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - November 15, 2018 Category: Respiratory Medicine Source Type: news

Rural Americans More Likely to Die from Preventable Causes
Blog post from the National Conference of State Legislatures celebrating National Rural Health Day and drawing attention to rural health disparities. Although the country as a whole has seen declines in four of five leading causes of death, that decline is slower in rural areas. Rural people experience higher death rates from heart disease, cancer, unintentional injury, chronic lower respiratory disease, and stroke. (Source: News stories via the Rural Assistance Center)
Source: News stories via the Rural Assistance Center - November 15, 2018 Category: Rural Health Source Type: news

Researchers to study drivers of asthma in Puerto Rico
(National Jewish Health) Researchers at the University of California, San Francisco, National Jewish Health and Centro de Neumolog í a Pedi á trica in Puerto Rico have been awarded nearly $10 million in a 5-year grant to understand the root causes of asthma in Puerto Rico, where asthma prevalence and deaths are among the highest in the world. The team will follow 4,000 children from birth through early childhood to study how genes and viral infections affect respiratory disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 15, 2018 Category: International Medicine & Public Health Source Type: news

Glenmark Pharmaceuticals Announces New Data Presentations on Ryaltris at the ACAAI Annual Scientific Meeting 2018
MAHWAH, N.J., Nov. 15, 2018 /PRNewswire/ -- Glenmark Pharmaceuticals, a global pharmaceutical company, today announced that the company is presenting new data for for its leading respiratory pipeline candidate Ryaltris (rye - al' - tris)... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - November 15, 2018 Category: Drugs & Pharmacology Source Type: news

Protein assemblies ejected directly from native membranes yield complexes for mass spectrometry
Membrane proteins reside in lipid bilayers and are typically extracted from this environment for study, which often compromises their integrity. In this work, we ejected intact assemblies from membranes, without chemical disruption, and used mass spectrometry to define their composition. From Escherichia coli outer membranes, we identified a chaperone-porin association and lipid interactions in the β-barrel assembly machinery. We observed efflux pumps bridging inner and outer membranes, and from inner membranes we identified a pentameric pore of TonB, as well as the protein-conducting channel SecYEG in association wit...
Source: ScienceNOW - November 15, 2018 Category: Science Authors: Chorev, D. S., Baker, L. A., Wu, D., Beilsten-Edmands, V., Rouse, S. L., Zeev-Ben-Mordehai, T., Jiko, C., Samsudin, F., Gerle, C., Khalid, S., Stewart, A. G., Matthews, S. J., Grünewald, K., Robinson, C. V. Tags: Biochemistry reports Source Type: news

FDA Warns Against Off-Label Use of Implantable Pain Pumps
FDA is cautioning doctors and patients about the serious complications that can occur when using medications not approved for use with implanted pumps that deliver medication into the spinal fluid to treat or manage pain. Complications may include dosing errors, pump failure, opioid withdrawal, and infection, not to mention pain,  muscle spasms, cognitive changes, weakness, and cardiac or respiratory distress. “The treatment of pain has become increasingly complex. While medical devices, such as implanted pumps that deliver medication directly into the spinal fluid, have the potent...
Source: MDDI - November 14, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Regulatory and Compliance Implants Source Type: news

Cochlear joins $17m round for sleep apnea nueromod dev Nyxoah
Cochlear Ltd. (ASX:COH) has joined a $17.1 million (EU €15 million) funding round for Nyxoah to support the development and commercialization of its hypoglossal nerve stim therapy for treating obstructive sleep apnea. Australian hearing tech developer Cochlear lead the round, investing $14.7 million (EU €13 million). The round was also joined by several existing Nyxoah shareholders, the Belgian company said. As part of the funding round, a member of Cochlear has joined Nyxoah’s board of directors. “Cochlear actively monitors the market for novel technologies and implantable devices that over the ...
Source: Mass Device - November 14, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Respiratory cochlear Nyxoah Source Type: news

ResMed closes $750m MatrixCare buy
ResMed (NYSE:RMD) said today that it closed the $750 million acquisition of MatrixCare and its post-acute-care software. The San Diego-based respiratory care giant said it funded the buyout, which represents a 25x EBITDA multiple, using its credit facility. Bloomington, Minn.-based MatrixCare put up sales of $122 million last year, ResMed said. “We’re all excited to have quickly closed this important deal and can officially welcome MatrixCare to the ResMed family,” ResMed CEO Mick Farrell said in prepared remarks. “ResMed is the world’s top tech-driven medical device c...
Source: Mass Device - November 14, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Mergers & Acquisitions Respiratory Software / IT Wall Street Beat MatrixCare ResMed Inc. Source Type: news

Vapotherm prices $56m IPO
Vapotherm yesterday priced an initial public offering, aiming to raise $56 million for its respiratory device. Exeter, N.H.-based Vapotherm developed the Precision Flow line of devices to provide high-velocity heated, humidified and oxygenated air to treat patients with conditions such as pneumonia, chronic obstructive pulmonary disease, asthma and heart failure. Some 1,200 of the devices have been sold in the U.S., mostly into hospital ICUs, the company said. Vapotherm said it plans to issue 4 million shares at $14 apiece, hitting the low end of its prior range. The offering also includes a 30-day underwrit...
Source: Mass Device - November 14, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Featured Funding Roundup Initial Public Offering (IPO) Respiratory Wall Street Beat Vapotherm Source Type: news

Africa: It's Time to Go Back to Basics in the Fight Against Childhood Pneumonia
[The Conversation Africa] Pneumonia is a respiratory infection that affects the lungs. The viruses and bacteria that cause the disease are spread through airborne droplets from a cough or sneeze. An infection can cause the lungs to fill with pus and fluid, making breathing and oxygen intake difficult. And while anyone can get pneumonia, children with weakened immune systems or underlying illnesses are more susceptible. That's why, pneumonia kills more than a million children every year across the world. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 14, 2018 Category: African Health Source Type: news

New virtual reconstruction of a Neanderthal thorax suggests another breathing mechanism
(University of the Basque Country) A research team, led by Dr Asier G ó mez-Olivencia, an Ikerbasque research fellow at the University of the Basque Country (UPV/EHU), and Dr Ella Been of the Ono Academic College of Tel Aviv, has carried out the first virtual reconstruction of the full fossil ribcage of the Neanderthal individual known as Kebara 2. The results show significant morphological differences pointing to a respiratory mechanism that was different in Neanderthals compared with that of modern humans. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - November 14, 2018 Category: Biology Source Type: news

More U.S. Kids Have Recently Been Diagnosed with a Mysterious Paralyzing Illness
(NEW YORK) — More children have been diagnosed with a mysterious paralyzing illness in recent weeks, and U.S. health officials said Tuesday that they still aren’t sure what’s causing it. This year’s count could surpass the tallies seen in similar outbreaks in 2014 and 2016, officials said. Fortunately, the disease remains rare: This year, there have been 90 cases spread among 27 states, the Centers for Disease Control and Prevention said. It’s not clear what’s causing some children to lose the ability to move their face, neck, back, arms or legs. The symptoms tend to occur about a week a...
Source: TIME: Health - November 13, 2018 Category: Consumer Health News Authors: MIKE STOBBE / AP Tags: Uncategorized onetime public health Source Type: news

AstraZeneca to divest US Synagis rights to Sobi
AstraZeneca has agreed to sell US rights to Synagis (palivizumab) used for the prevention of serious lower respiratory tract infection (LRTI) caused by respiratory syncytial virus (RSV) to Swedish Orphan Biovitrum AB (publ) (Sobi). Sobi will commercialise Synagis in the US and around 130 AstraZeneca employees will transfer to Sobi as part of the transaction. (Source: World Pharma News)
Source: World Pharma News - November 13, 2018 Category: Pharmaceuticals Tags: Featured AstraZeneca Business and Industry Source Type: news

Secondhand Smoke
Title: Secondhand SmokeCategory: Diseases and ConditionsCreated: 2/12/2010 12:00:00 AMLast Editorial Review: 11/13/2018 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - November 13, 2018 Category: Respiratory Medicine Source Type: news

Medical News Today: What to know about bradypnea (slow breathing)
Bradypnea is when a person is breathing at a slower rate than is usual for their age and activity level. Learn about bradypnea here, including its definition, causes, and treatment. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 12, 2018 Category: Consumer Health News Tags: Respiratory Source Type: news

Breaking the Smoking-Drinking Connection
Title: Breaking the Smoking-Drinking ConnectionCategory: Health NewsCreated: 11/12/2018 12:00:00 AMLast Editorial Review: 11/12/2018 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - November 12, 2018 Category: Respiratory Medicine Source Type: news

How pneumococci challenge our immune system
(Karolinska Institutet) Pneumococci are the most common cause of respiratory tract infections, such as otitis and sinusitis, as well as of severe infections like pneumonia and meningitis. A new study from Karolinska Institutet in Sweden published in Nature Microbiology shows how the bacteria can inhibit immune cell reaction and survive inside cells to give rise to pneumonia. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 12, 2018 Category: International Medicine & Public Health Source Type: news

A hub for respiratory care commissioning
The Primary Care Respiratory Academy Commissioning Platform aims to offer the tools and resources you need to optimise respiratory outcomes in your population. (Source: NHS Networks)
Source: NHS Networks - November 12, 2018 Category: UK Health Source Type: news

Physicians to NRA: This Is Our Lane Physicians to NRA: This Is Our Lane
Clinicians tweet their disgust at a National Rifle Association (NRA) report and tweet that attacked an ACP article aimed at reducing gun violence.Medscape Medical News (Source: Medscape Pulmonary Medicine Headlines)
Source: Medscape Pulmonary Medicine Headlines - November 9, 2018 Category: Respiratory Medicine Tags: Internal Medicine News Source Type: news

FDA to Ban Most Flavored E-Cigarettes
Title: FDA to Ban Most Flavored E-CigarettesCategory: Health NewsCreated: 11/9/2018 12:00:00 AMLast Editorial Review: 11/9/2018 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - November 9, 2018 Category: Respiratory Medicine Source Type: news

U.S. Smoking Rates Hit Record Low
Title: U.S. Smoking Rates Hit Record LowCategory: Health NewsCreated: 11/8/2018 12:00:00 AMLast Editorial Review: 11/9/2018 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - November 9, 2018 Category: Respiratory Medicine Source Type: news

Hypersensitivity Pneumonitis
Title: Hypersensitivity PneumonitisCategory: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 11/9/2018 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - November 9, 2018 Category: Respiratory Medicine Source Type: news

FDA Says Primatene Mist Inhaler is Back for Asthmatics
Title: FDA Says Primatene Mist Inhaler is Back for AsthmaticsCategory: Health NewsCreated: 11/8/2018 12:00:00 AMLast Editorial Review: 11/9/2018 12:00:00 AM (Source: MedicineNet Asthma General)
Source: MedicineNet Asthma General - November 9, 2018 Category: Respiratory Medicine Source Type: news

Can't shake a cold? Try these 10 techniques!
Some 70 percent of us will get a respiratory infection each year. It's the most common reason anyone goes to a doctor. There is little you can do to speed it up - but these 10 tips may help you, though. (Source: the Mail online | Health)
Source: the Mail online | Health - November 8, 2018 Category: Consumer Health News Source Type: news

14 Treated for Carbon Monoxide Exposure at Downtown Nashville Hotel
  NASHVILLE, Tenn. (WKRN) - Crews with the Nashville Fire Department were called to the Westin Nashville in downtown Wednesday morning for a carbon monoxide incident. The leak was reported around 6:45 a.m. at the hotel on Clark Place. At first, six people reported symptoms of CO exposure. The number of people feeling sick rose through the day. By 2 p.m., 14 people were treated by medics, including six who were taken to Vanderbilt University Medical Center. (Source: JEMS: Journal of Emergency Medical Services News)
Source: JEMS: Journal of Emergency Medical Services News - November 8, 2018 Category: Emergency Medicine Authors: WKRN Web Staff Tags: Airway & Respiratory News News Videos Source Type: news